[Evaluation of the effectiveness of dalargin in treating exacerbated peptic ulcer under outpatient conditions at medical health units].
D000328:Adult; D000553:Ambulatory Care; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy*; D013997:Time Factors
D000897:Anti-Ulcer Agents; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Otsenka éffectivnosti dalargina pri lechenii obostreniia iazvennoĭ bolezni v ambulatornykh usloviiakh medsanchasteĭ.